RhumbLine Advisers
CGON icon

RhumbLine Advisers’s CG Oncology CGON Stock Holding History

RhumbLine Advisers’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.81M Buy
71,082
+481
+0.7% +$27.3K ﹤0.01% 1415
2025
Q4 		$2.93M Sell
70,601
-10,157
-13% -$420K ﹤0.01% 1670
2025
Q3 		$3.25M Sell
80,758
-1,666
-2% -$48.4K ﹤0.01% 1644
2025
Q2 		$2.14M Buy
82,424
+7,735
+10% +$186K ﹤0.01% 1847
2025
Q1 		$1.83M Buy
74,689
+5,673
+8% +$160K ﹤0.01% 1850
2024
Q4 		$1.98M Buy
69,016
+1,458
+2% +$49.9K ﹤0.01% 1883
2024
Q3 		$2.55M Buy
67,558
+33,329
+97% +$1.17M ﹤0.01% 1773
2024
Q2 		$1.08M Buy
34,229
+3,940
+13% +$137K ﹤0.01% 2199
2024
Q1 		$1.33M Buy
+30,289
New +$1.24M ﹤0.01% 2102

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM